© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
SI-BONE, Inc. (SIBN) stock declined over -1.28%, trading at $17.76 on NASDAQ, down from the previous close of $17.99. The stock opened at $17.73, fluctuating between $17.50 and $18.27 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 31, 2026 | 17.90 | 18.27 | 17.50 | 17.76 | 366.41K |
| Jul 30, 2026 | 18.44 | 18.59 | 17.91 | 17.99 | 476.07K |
| Jul 29, 2026 | 17.92 | 18.65 | 17.80 | 18.44 | 596.65K |
| Jul 28, 2026 | 17.72 | 18.24 | 17.58 | 17.93 | 704.89K |
| Jul 27, 2026 | 16.91 | 17.26 | 16.73 | 17.05 | 616.79K |
| Jul 24, 2026 | 16.36 | 16.87 | 16.36 | 16.62 | 381.07K |
| Jul 23, 2026 | 16.49 | 16.63 | 16.26 | 16.47 | 331.11K |
| Jul 22, 2026 | 17.02 | 17.29 | 16.59 | 16.71 | 408.08K |
| Jul 21, 2026 | 16.89 | 17.33 | 16.81 | 17.04 | 436.9K |
| Jul 20, 2026 | 17.28 | 17.36 | 16.99 | 17.12 | 371.8K |
| Jul 17, 2026 | 17.48 | 17.71 | 16.86 | 17.38 | 403.78K |
| Jul 16, 2026 | 17.55 | 18.17 | 17.14 | 17.72 | 552.85K |
| Jul 15, 2026 | 16.73 | 17.36 | 16.73 | 17.25 | 447.37K |
| Jul 14, 2026 | 17.48 | 17.56 | 16.42 | 16.91 | 638.99K |
| Jul 13, 2026 | 17.56 | 18.13 | 17.56 | 17.85 | 411.08K |
| Jul 10, 2026 | 17.53 | 17.76 | 16.86 | 17.56 | 421.15K |
| Jul 09, 2026 | 16.97 | 17.71 | 16.84 | 17.42 | 613.03K |
| Jul 08, 2026 | 17.05 | 17.35 | 16.83 | 16.89 | 1.29M |
| Jul 07, 2026 | 17.82 | 17.93 | 17.16 | 17.30 | 779.69K |
| Jul 06, 2026 | 16.97 | 17.86 | 16.93 | 17.68 | 414K |
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
| Employees | 376 |
| Beta | 0.67 |
| Sales or Revenue | $138.89M |
| 5Y Sales Change% | 0.038% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |